Trial intelligence / Profile preview

Intraoperative Goal Directed Fluid Therapy in Lean and Obese Patients

NCT00860704Phase 4Completed

Sponsor
Medical University of Vienna
Start
Nov 2007
Primary completion
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of lactated ringer's solution (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Hemodynamic fluid responses. Started Nov 2007; status: completed.

02

Drugs

lactated ringer's solution

Beyond the preview

Go deeper on NCT00860704.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00860704.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call